Clinical Trial Update: Docosahexaenoic Acid in the Treatment of Autism [NA]

View source ↗

Summary

This clinical trial update notes that the Mayo Clinic-sponsored study of docosahexaenoic acid for autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Mayo Clinic | Conditions: Autism | NA | Status: COMPLETED